CONTROL OF COMMUNICABLE DISEASES

(DOH PHILIPPINES) DOH-PROGRAMS IN THE CONTROL OF SPECIFIC

COMMUNICABLE DISEASES:
COMMUNICABLE DISEASES National TB (TUBERCULOSIs) Control Program
https://www.doh.gov.ph/malaria-control-program
Contagious Disease- "direct physical contact" Vision
Infectious Disease- transmitted indirectly through: TB -free Philippines
contaminated food, body fluids, objects, airborne inhalation, Mission
or through vector  To reduce TB burden (TB incidence and TB mortality)
organisms  To achieve catastrophic cost of TB-affected households
 To responsively deliver TB service
EPIDEMIOLOGIC TRIANGLE MODEL Program Components
Agent-an organism involved in the development of a disease  Health Promotion
Host-any organism that harbors and provide nutrition for  Financing and Policy
the agent  Human Resource
Environment-refers to the condition in which the agent may  Information System
exist, survive or originate  Regulation
 Service Delivery
ULTIMATE GOAL: ELIMINATION AND ERADICATION  Governance
RA 10767 : Comprehensive TB Elimination Plan Act of 2016
ITFDE (International Task Force for Disease Eradication)
National Leprosy Control Program
TARGETED DISEASES AS MANDATED BY WHO& DOH https://www.doh.gov.ph/leprosy-control-program
PHILIPPINES The National Leprosy Control Program (NLCP) is a multi-
 Tuberculosis agency effort to control Leprosy in the country with private
 Leprosy and public partnership in achieving its goals to lessen the
 Malaria burden of the disease and its mission to have a leprosy-free
 Filariasis country.
 Rabies VISION
 STDIHIVIAIDS Leprosy-free Philippines by the year 2022
 Dengue MISSION
 Schistosomiasis To ensure the provision of comprehensive, integrated
quality leprosy services at all levels of healthcare
FUNCTIONS OF THE PUBLIC HEALTH NURSE IN
THE CONTROL OF COMMUNICABLE DISEASES: OBJECTIVES
1. Report immediately to the Municipal Health Office  To further reduce the disease burden and sustain
any known case of notifiable disease. provision of high-quality leprosy services for all affected
2. Refer immediately to the nearest hospital communities ensuring that the principle of equity and
3. Conduct a strong health education program directed social justice are followed
toward prevention of an outbreak.  To decrease by 50% the identified hyper endemic cities
4. Assist in the diagnosis of the suspect based on the and municipalities
signs and symptoms PROGRAM COMPONENTS
5. Conduct epidemiologic investigations as a means of  Early diagnosis and treatment
contacting families case finding and individual as  Integration of leprosy services
well as Community health education.  Referral system
 Case detection and diagnosis
 Advocacy and IEC focusing on stigma discrimination
and reduction
 Prevention of Deformity, self-care and rehabilitation
 Recording and reporting
 Monitoring, supervision and evaluation
Malaria Control Program
https://www.doh.gov.ph/malaria-control-program
Malaria is a life-threatening disease caused by plasmodium
parasites transmitted by anopheles mosquito or rarely
through blood transfusion and sharing of contaminated
needles causing acute febrile illness and symptoms in the
form of fever, headache and chills. Untreated, P. falciparum
malaria may progress to severe illness and possibly, death.
DOH-NMCEP aims to eliminate malaria by adopting a health
system focused approach to achieve universal coverage with
quality-assured malaria diagnosis and treatment, strengthen
governance and human resources, maintain the financial
support needed, and ensure timely and accurate
information management.
Currently, only 7 provinces remain with local transmission of
the disease. One of these provinces is Palawan, which holds
more than 90% of the country’s malaria cases.
VISION
A Malaria–Free Philippines by 2030
MISSION
Further accelerate malaria control and transition towards
elimination
OBJECTIVES
1. (Universal Access) – To ensure universal access to reliable
diagnosis, highly effective and appropriate treatment and
preventive measures
2.(Governance and Human Resources) – To strengthen
governance and human resources capacity at all levels to
manage and implement malaria interventions
3. (Health Financing) – To secure government and non-
government financing to sustain malaria control and
elimination efforts at all levels
4. (Health Information and Regulation) – To ensure quality
malaria services, timely detection of infection and
immediate response, and information and evidence to guide
malaria elimination
PROGRAM COMPONENTS
 Program Management and Health System -
 Diagnosis and Treatment
 Vector Control
 Advocacy and Social Mobilization
 Surveillance, Outbreak Preparedness and Response
 Monitoring and Evaluation
 Partnerships
 Assessment of Other Factors
Filariasis Elimination Program
https://www.doh.gov.ph/national-filariasis-elimination-
program
The Elimination started in 2001 after a pilot study using the
combination drugs in 2000 in five selected municipalities in
five provinces.
Total no. of province: 81
Total population in the country: 103, 741, 330 as of 2018
Total Endemic Provinces: 46 Provinces in 12 Regions
Total Endemic Population: 8 Million
Parasite: Majority is Wuchereria bancrofti
Vectors incriminated: Aedes poecilius, Anopheles flavirostris
VISION
Healthy and productive individuals and families for Filariasis-
Free Philippines
MISSION
Elimination of Filariasis as a public health problem thru
comprehensive approach and universal access to quality
health services
OBJECTIVES
 To sustain transmission interruption in provinces
through strengthening of surveillance
 To intensify interventions and interrupt transmission in
persistent infection provinces
 To strengthen Morbidity Management & Disability
Prevention (MMDP) activities and services to alleviate
suffering among chronic patients
 To strengthen the health system capacity to secure LF
elimination
 Secure adequate investment from governmental and
non-governmental sources to sustain all program
objective
PROGRAM COMPONENTS
Filariasis is a major parasitic infection, which continues to be
a public health problem in the Philippines. It was first
discovered in the Philippines in 1907 by foreign workers.
Consolidated field reports showed a prevalence rate of 9.7%
per 1000 population in 1998. It is the second leading cause
of permanent and long-term disability. The disease affects
mostly the poorest municipalities in the country about 76%
of the case live in the 4th-6th class type of municipalities.
The World Health Assembly in 1997 declared “Filariasis
Elimination as a priority” where the WHO’s call for global
elimination was created (WHA 50.29 Resolution: Elimination
of lymphatic filariasis as a public health problem). This was
followed by the Global Program for Elimination of Lymphatic
Filariasis, launched by World Health Organization which has
two main components that were adopted by the national
program:
 INTERRUPTION OF TRANSMISSION: Elimination level
prevalence of microfilaremia of less than 1% and
Antigen rate of < 1% through Mass Drug Administration
(MDA) 2. Adolescent females
 CONTROL AND REDUCE THE MORBIDITY by alleviating Albendazole 400 mg once a year
the sufferings and disability caused by its clinical Mebendazole 500 mg once a year
manifestations through Morbidity Management
Disability Prevention (MMDP) 3. Pregnant women
A major strategy of the Elimination Plan was the Mass t is recommended that all pregnant women who consult the
Annual Treatment using the combination drug, health be given anthelminthic drug once in the 2nd
Diethylcarbamazine Citrate and Albendazole for a minimum trimester of
of 5 years to individuals ages 2 years old and above living in pregnancy. In areas where hookworm is endemic:
established endemic areas after the issuance from WHO of Where hookworm prevalence is 20-30%
the safety data on the use of the drugs. The Philippine Plan Albendazole 400 mg once In the 2nd trimester
was approved by WHO which gave the government free Mebendazole 500 mg once in the 2nd trimester
supply of the Albendazole (donated by GSK thru WHO) for Where hookworm prevalence is > 50%,
filariasis elimination. An Administrative Order declaring repeat treatment in the 3rd Trimester
“November as Filariasis Mass Treatment Month was signed
by the Secretary of Health was issued on that same year. In 4.Special groups, e.g., food handlers and operators, soldiers,
2010, a guideline in the prevention of disabilities due to farmers and indigenous people. Selective deworming is the
lymphatic Filariasis in support to effective implementation ofgiving of anthelminthic drug to an individual based on the
management of morbidity and prevention of disabilities due diagnosis of current infection. However, certain groups of
to Filariasis people should be given deworming drugs regardless of their
status once they consult the health center. Special groups
like soldiers, famers, food handlers and operators, and
HCP interventions: Indigenous people are at risk of morbidity because of their
1 Chemotherapy remains as the core package in helminth exposure to different intestinal parasites in relation to their
infection control occupation or cultural practices. For the clients who will be
2 Water, sanitation and hygiene (WASH) Serves as the dewormed selectively, treatment shall given
cornerstone in reducing the prevalence of worm infection be anytime at the health centers.
3. Promotion of desired behaviors ensures that these efforts
on chemotherapy and WASH are translated into actual
healthy practices and better utilization of these facilities. National Safe Motherhood Program
 Enabling mechanisms must therefore be established to https://www.doh.gov.ph/national-safe-motherhood-
Support their implementation. An enabling environment program
entails good governance of the IHCP at all levels of Vision
operations For Filipino women to have full access to health services
towards making their pregnancy and delivery safer
Targets and Doses Mission
1.Children aged 1 year to 12 years old Guided by the Department of Health FOURmula One Plus
For children 12-24 months old thrust and the Universal Health Care Frame, the National
>Albendazole-200 mg. single dose every 6 months. Since the Safe Motherhood Program is committed to provide rational
preparation is 400mg, the tablet is halve and can be chewed and responsive policy direction to its local government
by the child or taken with a glass of water partners in the delivery of quality maternal and newborn
Mebendazole 500 mg, single dose every 6 months health services with integrity and accountability using
For children 24 months old and above proven and innovative approaches
Albendazole-400 mg, single dose every 6 months
Mebendazole-500 mg, single dose every 6 months
Note: f Vitamin A and deworming drug are given
simultaneously during the GPactlvity, elther drug
can be given first.
  Development and dissemination of Information,
Education Communication materials
 Advocacy and social mobilization for FP
 Network of Training Providers
 31 Training Centers that provide BEmONC Skills
Objectives Training
The Program contributes to the national goal of improving  Monitoring, Evaluation, Research, and Dissemination
women’s health and well-being by: with support from the Epidemiology Bureau and Health
 Collaborating with Local Government Units in Policy Development and Planning Bureau
establishing sustainable, cost-effective approach of  Monitoring and Supervision of Private Midwife Clinics in
delivering health services that ensure access of cooperation with PRC Board of Midwifery and
disadvantaged women to acceptable and high quality Professional Midwifery Organizations
maternal and newborn health services and enable them  Maternal Death Reporting and Review System in
to safely give birth in health facilities near their homes collaboration with Provincial and City Review Teams
 Establishing core knowledge base and support systems  Annual Program Implementation Reviews with
that facilitate the delivery of quality maternal and Provincial Health Officers and Regional Coordinators
newborn health services in the country.
Program Components
Component A: Local Delivery of the Maternal–Newborn
Service Package
-This component supports LGUs in establishing and
mobilizing the service delivery network of public and private
providers to enable them to deliver the integrated maternal-
newborn service package. In each province and city, the
following shall continue to be undertaken:
 Establishment of critical capacities to provide quality
maternal-newborn services through the organization
and operation of a network of Service Delivery Teams
consisting of:
 Barangay Health Workers
 BEmONC Teams composed of Doctors, Nurses and
Midwives
 In collaboration with the Centers for health
Development and relevant national offices:
Establishment of Reliable Sustainable Support Systems
for Maternal-Newborn Service Delivery through such
initiatives as:
 Establishment of Safe Blood Supply Network with
support from the National Voluntary Blood Program
 Behavior Change Interventions in collaboration with
the Health Promotion and Communication Service
 Sustainable financing of maternal - newborn services
and commodities through locally initiated revenue
generation and retention activities including PhilHealth
accreditation and enrolment.
Component B: National Capacity to Sustain Maternal-
Newborn Services
 Operational and Regulatory Guidelines
 Identification and profiling of current FP users and
identification of potential FP clients and those with
unmet need for FP (permanent or temporary methods)
 Mainstreaming FP in the regions with high unmet need
for FP